BioSpace News Archive

Light therapy or phototherapy is a treatment type wherein a patient is exposed to an artificial light source. It affects brain chemicals linked to mood and sleep, and also helps to reset the circadian rhythms, which control the sleep-wake cycle.

The global medical walkers market is likely to witness a notable growth in the near future. This is mainly due to the presence of key drivers such as increasing number of orthopedic diseases, short term disabilities, and medical emergencies.

Stem cells are body’s raw materials or cells from which all other cells with specialized functions are generated. These cells can be guided to become specific cells that regenerate and repair diseased or damaged tissues in patients suffering from various diseases.

The global herbal toothcare market is set to expand at a respectable pace in the years to follow. The domain of dentistry has shown a sense of pragmatism in endorsing new technologies for improved oral health.

Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) announced today that it has entered into an exclusive option agreement with Joslin Diabetes Center for patent filings on certain additional novel biomarkers in kidney disease for development and deployment in the KidneyIntelX in vitro prognostic platform.

Centene Corporation and the Pro Football Hall of Fame recently launched a PSA campaign to educate people across the U.S. about the safety and importance of the COVID-19 vaccine, with a particular focus on communities of color.

AnemoCheck Mobile is the first app of its kind to offer patients a remote screening option for anemia, without the need for a blood test

Drug development leader brings extensive expertise in clinical and overall development strategy and execution across a wide range of therapeutic areas

StrideBio receives exclusive license to novel cross-species evolved AAV vectors and an enzymatic approach for neutralizing antibody evasion

Antibe Therapeutics Inc., a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies for inflammation arising from a wide range of medical conditions, is pleased to announce its participation in the Bloom Burton & Co. Healthcare Investor Conference being held virtually on Tuesday, April 20 and Wednesday, April 21.